The grouping of ES and OS together, however, makes it difficult to determine a true risk of SMN for ES survivors given that the cohort may include OS patients with a high genetic risk for SMN (e.g. germline p53 mutations/ Li-Fraumeni Syndrome(LFS)). This evidence concerns the gene TP53 and Li-Fraumeni syndrome.